◀ Back to ICAM1

ICAM1 — MAP2K1

Text-mined interactions from Literome

Chen et al., Mol Pharmacol 2000 : However, neither the mitogen activated protein kinase kinase inhibitor PD 98059 nor the p38 inhibitor SB 203580 affected IL-1beta induced ICAM-1 expression
Yang et al., J Cell Physiol 2010 (Arthritis, Rheumatoid) : IL-1beta induced ICAM-1 expression, extracellular signal regulated kinase ( ERK ) and c-Jun-N-terminal kinase (JNK) phosphorylation, AP-1 activation, and nuclear factor-kappaB (NF-kappaB) p65 translocation were attenuated by the inhibitors of MEK1/2 ( U0126 ), JNK ( SP600125 ), AP-1 ( tanshinone IIA ), and NF-kappaB ( helenalin ) or transfection with respective short hairpin RNA plasmids
Cho et al., The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 2013 : PD98059, inhibitor of mitogen activated protein kinase kinase/extracellular signal regulated kinase ( MEK/ERK ) did not affect VCAM-1 and ICAM-1 expression stimulated with LPS